Treatment patterns and oncological outcome of patients with advanced small intestinal neuroendocrine tumors: real-world data from the Medical University of Vienna.
Philipp MelhornElisabeth Kretschmer-ChottLadislaia WolffAlexander HaugPeter MazalMarkus RadererBarbara KiesewetterPublished in: Therapeutic advances in medical oncology (2022)
While peritoneal carcinomatosis emerged as an adverse prognostic factor for PFS in this collective, the long-term outcome of patients treated at a specialized NET center using approved therapies appeared comparable to pivotal studies in SI-NET.